At a glance
ClinicalIndex Comparison RecordN/ACompleted· 416 enrolled
Drug / intervention
Antenatal Obesity Treatment (AO)behavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Partnering With WIC to Prevent Excessive Weight Gain in Pregnancy
In Brief
A clinical study evaluating Antenatal Obesity Treatment (AO) for Obesity and 2 related conditions. Completed, enrolled 416 participants across 1 site.
Detailed Summary
The purpose of this study is to determine the effect of an antenatal obesity treatment on gestational weight gain when integrated into Philadelphia WIC.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObesity, Overweight, Pregnancy Related
CountriesUnited States
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartJul 2018
First PostedOct 2018
Primary CompletionOct 2023
Study CompletionNov 2024
TodayJul 2026
First PostedOct 16, 2018
Enrollment StartJul 1, 2018
Primary CompletionOct 10, 2023
Study CompletionNov 30, 2024
TodayJul 2, 2026
Enrollment to primary: 5.3 yearsPosted 7.7 years ago
Interventions
Antenatal Obesity Treatment (AO)behavioral
Participants in the treatment (AO) arm will receive a 4-component intervention: 1)Behavior change goals; 2)Self-monitoring; 3)Tailored skills training; and 4)WIC provider counseling Both treatment and usual care arms will receive the current standard of care offered to postpartum mothers at WIC.